Dr. Roxana Mehran
Adorable Joan of Arc’s
Dr. Roxana Mehran (USA) is a Professor at the Icahn School of Medicine at Mount Sinai and the Director of Interventional Cardiovascular Research and Clinical Trials. She has led numerous global studies, developed risk scores for bleeding and kidney injury, and contributed to national clinical guidelines. Her landmark TWILIGHT trial, published in The New England Journal of Medicine (NEJM) in 2019, evaluated ticagrelor monotherapy after PCI. With over 1,000 peer-reviewed articles and 200,000 citations, she is a prominent figure in cardiovascular research. A strong advocate for women in medicine, particularly cardiology, she co-founded Women as One to support women physicians’ careers. Her achievements include receiving the Bernadine Healy Leadership Award in 2017, the Nanette Wenger Award in 2018, the Andreas Gruntzig Award, and the Ellis Island Medal of Honor in 2019. She has contributed to TCTAP for over 20 years and has been nominated as a “Master of the Masters” Award at TCTAP in 2025.
As a vivid memory, almost every year when she attended our TCTAP meetings, she would visit our hospital (AMC) and join us in performing complex PCI cases in the cath lab. We learned a great deal from each other, and she had a particular interest in left main stenting procedures. She was the first female interventional cardiologist in our lab and one of the most remarkable and elegant doctors I have ever known. She always greeted us with a kind smile. And as time passed, Dr. Young-Hak Kim from our department had the opportunity to pursue postdoctoral research training under her mentorship at Columbia University.
Dr. Roxana Mehran (USA) is a Professor at the Icahn School of Medicine at Mount Sinai and the Director of Interventional Cardiovascular Research and Clinical Trials. She has led numerous global studies, developed risk scores for bleeding and kidney injury, and contributed to national clinical guidelines. Her landmark TWILIGHT trial, published in The New England Journal of Medicine (NEJM) in 2019, evaluated ticagrelor monotherapy after PCI. With over 1,000 peer-reviewed articles and 200,000 citations, she is a prominent figure in cardiovascular research. A strong advocate for women in medicine, particularly cardiology, she co-founded Women as One to support women physicians’ careers. Her achievements include receiving the Bernadine Healy Leadership Award in 2017, the Nanette Wenger Award in 2018, the Andreas Gruntzig Award, and the Ellis Island Medal of Honor in 2019. She has contributed to TCTAP for over 20 years and has been nominated as a “Master of the Masters” Award at TCTAP in 2025.
As a vivid memory, almost every year when she attended our TCTAP meetings, she would visit our hospital (AMC) and join us in performing complex PCI cases in the cath lab. We learned a great deal from each other, and she had a particular interest in left main stenting procedures. She was the first female interventional cardiologist in our lab and one of the most remarkable and elegant doctors I have ever known. She always greeted us with a kind smile. And as time passed, Dr. Young-Hak Kim from our department had the opportunity to pursue postdoctoral research training under her mentorship at Columbia University.